While Applied Therapeutics Inc has underperformed by -0.36%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, APLT rose by 418.38%, with highs and lows ranging from $10.62 to $1.79, whereas the simple moving average jumped by 56.36% in the last 200 days.
On July 31, 2024, William Blair started tracking Applied Therapeutics Inc (NASDAQ: APLT) recommending Outperform. A report published by RBC Capital Mkts on March 26, 2024, Initiated its previous ‘Outperform’ rating for APLT. Leerink Partners also rated APLT shares as ‘Outperform’, setting a target price of $12 on the company’s shares in an initiating report dated February 22, 2024. Barclays January 04, 2022d the rating to Equal Weight on January 04, 2022, and set its price target from $44 to $7. Goldman August 27, 2021d its ‘Neutral’ rating to ‘Sell’ for APLT, as published in its report on August 27, 2021. Goldman’s report from June 25, 2021 suggests a price prediction of $18 for APLT shares, giving the stock a ‘Neutral’ rating. Truist also rated the stock as ‘Buy’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Applied Therapeutics Inc (APLT)
One of the most important indicators of Applied Therapeutics Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. Taking into account the quick ratio of the company, currently set at 1.06, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and APLT is recording 2.67M average volume. On a monthly basis, the volatility of the stock is set at 6.89%, whereas on a weekly basis, it is put at 7.40%, with a gain of 10.87% over the past seven days. Furthermore, long-term investors anticipate a median target price of $12.75, showing growth from the present price of $9.59, which can serve as yet another indication of whether APLT is worth investing in or should be passed over.
How Do You Analyze Applied Therapeutics Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 25.33%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 86.86% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
APLT shares are owned by institutional investors to the tune of 86.86% at present.
